2 | Matteo Valeriohttps://matteovalerio.netlify.app/publication-type/2/2Wowchemy (https://wowchemy.com)en-usThu, 01 May 2025 00:00:00 +0000https://matteovalerio.netlify.app/media/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_512x512_fill_lanczos_center_3.png2https://matteovalerio.netlify.app/publication-type/2/Bone Metastases and Skeletal Complications: Information and Involvement of Patients with Cancer in the Treatment Pathwayhttps://matteovalerio.netlify.app/publication/gori-bone-2025/Thu, 01 May 2025 00:00:00 +0000https://matteovalerio.netlify.app/publication/gori-bone-2025/Adjuvant systemic therapy in early breast cancer and results of a prospective observational multicenter BRIDE study: patients outcome and adherence to guidelines in cancer clinical practicehttps://matteovalerio.netlify.app/publication/gori-adjuvant-2025/Tue, 08 Apr 2025 00:00:00 +0000https://matteovalerio.netlify.app/publication/gori-adjuvant-2025/pyBioPortal: a Python package for simplifying cBioPortal data access in cancer researchhttps://matteovalerio.netlify.app/publication/valerio-pybioportal-2025/Sat, 01 Feb 2025 00:00:00 +0000https://matteovalerio.netlify.app/publication/valerio-pybioportal-2025/Deep Neural Network Integrated into Network-Based Stratification (D3NS): A Method to Uncover Cancer Subtypes from Somatic Mutationshttps://matteovalerio.netlify.app/publication/valerio-deep-2024/Wed, 14 Aug 2024 00:00:00 +0000https://matteovalerio.netlify.app/publication/valerio-deep-2024/Follow-up of breast cancer: why is it necessary to start a Consensus in 2024?https://matteovalerio.netlify.app/publication/gori-follow-up-2024/Thu, 01 Feb 2024 00:00:00 +0000https://matteovalerio.netlify.app/publication/gori-follow-up-2024/Neoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE Studyhttps://matteovalerio.netlify.app/publication/gori-neoadjuvant-2023/Sun, 01 Oct 2023 00:00:00 +0000https://matteovalerio.netlify.app/publication/gori-neoadjuvant-2023/Activity of sotorasib against brain metastases from NSCLC harboring KRAS p.G12C mutation: a case reporthttps://matteovalerio.netlify.app/publication/inno-activity-2023/Tue, 20 Jun 2023 00:00:00 +0000https://matteovalerio.netlify.app/publication/inno-activity-2023/The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Studyhttps://matteovalerio.netlify.app/publication/muscaritoli-impact-2023/Thu, 01 Jun 2023 00:00:00 +0000https://matteovalerio.netlify.app/publication/muscaritoli-impact-2023/Humoral Effect of SARS-CoV-2 mRNA vaccination with booster dose in solid tumor patients with different anticancer treatmentshttps://matteovalerio.netlify.app/publication/piubelli-humoral-2023/Sun, 01 Jan 2023 00:00:00 +0000https://matteovalerio.netlify.app/publication/piubelli-humoral-2023/The predictive and prognostic role of metabolic and volume-based parameters of positron emission tomography/computed tomography as non-invasive dynamic biological markers in early breast cancer treated with preoperative systemic therapyhttps://matteovalerio.netlify.app/publication/inno-predictive-2022/Sat, 01 Jan 2022 00:00:00 +0000https://matteovalerio.netlify.app/publication/inno-predictive-2022/The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancerhttps://matteovalerio.netlify.app/publication/gori-herba-2019/Thu, 01 Aug 2019 00:00:00 +0000https://matteovalerio.netlify.app/publication/gori-herba-2019/Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Studyhttps://matteovalerio.netlify.app/publication/vitale-restaging-2018/Mon, 01 Oct 2018 00:00:00 +0000https://matteovalerio.netlify.app/publication/vitale-restaging-2018/Metabolic disorders across hepatocellular carcinoma in Italyhttps://matteovalerio.netlify.app/publication/morisco-metabolic-2018/Tue, 01 May 2018 00:00:00 +0000https://matteovalerio.netlify.app/publication/morisco-metabolic-2018/Diaphragm and lung–preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experiencehttps://matteovalerio.netlify.app/publication/ambrogi-diaphragm-2018/Sun, 01 Apr 2018 00:00:00 +0000https://matteovalerio.netlify.app/publication/ambrogi-diaphragm-2018/Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: a pilot case-control studyhttps://matteovalerio.netlify.app/publication/morisco-laser-2018/Sun, 01 Apr 2018 00:00:00 +0000https://matteovalerio.netlify.app/publication/morisco-laser-2018/Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practicehttps://matteovalerio.netlify.app/publication/giannini-patients-2017/Wed, 01 Nov 2017 00:00:00 +0000https://matteovalerio.netlify.app/publication/giannini-patients-2017/Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinomahttps://matteovalerio.netlify.app/publication/pecorelli-curative-2017/Wed, 01 Mar 2017 00:00:00 +0000https://matteovalerio.netlify.app/publication/pecorelli-curative-2017/Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinomahttps://matteovalerio.netlify.app/publication/cabibbo-hepatic-2017/Wed, 01 Feb 2017 00:00:00 +0000https://matteovalerio.netlify.app/publication/cabibbo-hepatic-2017/A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinomahttps://matteovalerio.netlify.app/publication/cabibbo-meta-analysis-2017/Sun, 01 Jan 2017 00:00:00 +0000https://matteovalerio.netlify.app/publication/cabibbo-meta-analysis-2017/Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferonhttps://matteovalerio.netlify.app/publication/petta-hepatocellular-2017/Sun, 01 Jan 2017 00:00:00 +0000https://matteovalerio.netlify.app/publication/petta-hepatocellular-2017/Molecular Biology Can Change the Classic Laboratory Approach for Intestinal Protozoan Infectionshttps://matteovalerio.netlify.app/publication/formenti-molecular-2017/Sun, 01 Jan 2017 00:00:00 +0000https://matteovalerio.netlify.app/publication/formenti-molecular-2017/The evolutionary scenario of hepatocellular carcinoma in Italy: an updatehttps://matteovalerio.netlify.app/publication/bucci-evolutionary-2016/Fri, 01 Jul 2016 00:00:00 +0000https://matteovalerio.netlify.app/publication/bucci-evolutionary-2016/Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinomahttps://matteovalerio.netlify.app/publication/farinati-development-2016/Fri, 01 Apr 2016 00:00:00 +0000https://matteovalerio.netlify.app/publication/farinati-development-2016/Years of life that could be saved from prevention of hepatocellular carcinomahttps://matteovalerio.netlify.app/publication/cucchetti-years-2016/Fri, 01 Apr 2016 00:00:00 +0000https://matteovalerio.netlify.app/publication/cucchetti-years-2016/Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcomehttps://matteovalerio.netlify.app/publication/bucci-comparison-2016/Mon, 01 Feb 2016 00:00:00 +0000https://matteovalerio.netlify.app/publication/bucci-comparison-2016/Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinomahttps://matteovalerio.netlify.app/publication/giannini-application-2016/Fri, 01 Jan 2016 00:00:00 +0000https://matteovalerio.netlify.app/publication/giannini-application-2016/Association between patient reported outcomes and vibratory perception threshold test for measuring neurotoxicity in patients with chemotherapy induced peripheral neuropathyhttps://matteovalerio.netlify.app/publication/lunardi-r-18-association-2015/Thu, 01 Jan 2015 00:00:00 +0000https://matteovalerio.netlify.app/publication/lunardi-r-18-association-2015/FDG-PET/CT as a predictor of pathological complete response (pCR) in breast cancer (BC) patients (pts) treated with neoadjuvant chemotherapy (NAC): a single center retrospective studyhttps://matteovalerio.netlify.app/publication/inno-a-20-fdg-petct-2015/Thu, 01 Jan 2015 00:00:00 +0000https://matteovalerio.netlify.app/publication/inno-a-20-fdg-petct-2015/P16 but not retinoblastoma expression is related to clinical outcome in no-special-type triple-negative breast carcinomashttps://matteovalerio.netlify.app/publication/bogina-p-16-2014/Sat, 01 Feb 2014 00:00:00 +0000https://matteovalerio.netlify.app/publication/bogina-p-16-2014/